Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

November 27, 2018 By Lynn Fugaro Leave a Comment

PPIs Side Effects

Proton pump inhibitors (PPIs) are used to treat heartburn, ulcers, and symptoms of acid reflux. Recent studies have found an increased risk of developing stomach cancer if you take these drugs. PPIs include popular prescription and over-the-counter (OTC) drugs such as Nexium (esomeprazole) and Prilosec (omeprazole). It was also found that people who used histamin-2 (H2) receptor antagonists, such as Tagamet (cimetidine) and Zantac (ranitidine), did not face the same risk. Further, the risk of developing stomach cancer with PPI use may have been known, or should have been anticipated, as far back as the 1980’s.

Heartburn Medications

PPIs are heavily prescribed, some say very overprescribed, for the following purposes:

  • Treat or prevent ulcers
  • Treat H. pylori infection, in combination with antibiotics
  • Treat symptoms of gastroesophageal reflux disease (GERD), also known as acid reflux
  • Heal erosion of the esophagus caused by acid reflux
  • Treat Barrett’s esophagus
  • Reduce acid production in Zollinger-Ellison syndrome
  • Other conditions in which reduction of stomach acid is beneficial

But PPIs are not your only options. H2 inhibitors are another type of antacid, and they have not been linked to increased instances of stomach cancer.

Increased Risk of Stomach Cancer

Near the end of 2017 two studies were published showing an increased risk of stomach cancer in PPI users. The study published in the journal Gut found that users were more than twice as likely to develop stomach cancer and that the risk increased with long-term use. Another study published in BMJ Open found a threefold increase of stomach cancer cases people using PPIs and none in those using H2 blockers.

If you have developed stomach cancer after or while using PPI drugs, please talk to an experienced defective drug attorney right away to learn more about your rights.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

Filed Under: Cancer, Drug Recalls, Proton pump inhibitors

Avatar

About Lynn Fugaro

Lynn has been writing web content since 2007 after a lengthy career as a middle school English teacher and administrator. Writing web content seemed a natural progression following a career teaching adolescents about the beauty and the power of the written word, and she quickly got hooked on the challenge of writing SEO- and reader-friendly content that could be found on Page 1 of Google and other search engines.

Having written content for physicians and attorneys for the first few years of her writing career, Lynn has most recently produced original, informative, entertaining, and relevant content for the entertainment industry, the automotive industry, senior communities, pet rescues and numerous other businesses hoping to increase website traffic and page views for all clients looking for informative, vibrant content.

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

RSS FDA Med Watch

  • 2023 Safety Communications
  • Evaluation of Safety Concerns with Certain Dental Devices Used on Adults – FDA Safety Communication
  • Jarman’s Midwest Cleaning Systems, Inc. Issues Voluntary Nationwide Recall of Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution and Isopropyl Alcohol Antiseptic 75% Topical Solution Hand Sanitizer Non-sterile Solution Due to Presence of Methanol
  • Risks with Exactech Joint Replacement Devices with Defective Packaging – FDA Safety Communication
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitroso-dabigatran (NDAB) Impurity
  • UPDATE: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants - FDA Safety Communication
  • 2023 Medical Device Recalls

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information
  • Possible Lawsuit: Birth Injury and Birth Defect Lawsuit News and Legal Information
  • Possible Lawsuit: Wyoming Medical Malpractice Lawsuit News & Legal Information

RSS Mass Tort News

RSS Health Industry

  • BREAKING: Gwyneth Paltrow Cleared In $3M Ski Crash Trial
  • Ex-CEO Whistleblower Nets $12M In Hospital's $69M FCA Deal
  • BREAKING: Trump Charged In Sealed NY Indictment

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2023 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in